Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE This study was conducted to describe the incidence of diabetes following pancreatic disease, assess how these patients are classified by clinicians, and compare clinical characteristics with type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS Primary care records in England (n = 2,360,631) were searched for incident cases of adult-onset diabetes between 1 January 2005 and 31 March 2016. We examined demographics, diabetes classification, glycemic control, and insulin use in those with and without pancreatic disease (subcategorized into acute pancreatitis or chronic pancreatic disease) before diabetes diagnosis. Regression analysis was used to control for baseline potential risk factors for poor glycemic control (HbA1c ≥7% [53 mmol/mol]) and insulin requirement. RESULTS We identified 31,789 new diagnoses of adult-onset diabetes. Diabetes following pancreatic disease (2.59 [95% CI 2.38–2.81] per 100,000 person-years) was more common than type 1 diabetes (1.64 [1.47–1.82]; P < 0.001). The 559 cases of diabetes following pancreatic disease were mostly classified by clinicians as type 2 diabetes (87.8%) and uncommonly as diabetes of the exocrine pancreas (2.7%). Diabetes following pancreatic disease was diagnosed at a median age of 59 years and BMI of 29.2 kg/m2. Diabetes following pancreatic disease was associated with poor glycemic control (adjusted odds ratio, 1.7 [1.3–2.2]; P < 0.001) compared with type 2 diabetes. Insulin use within 5 years was 4.1% (3.8–4.4) with type 2 diabetes, 20.9% (14.6–28.9) with diabetes following acute pancreatitis, and 45.8% (34.2–57.9) with diabetes following chronic pancreatic disease. CONCLUSIONS Diabetes of the exocrine pancreas is frequently labeled type 2 diabetes but has worse glycemic control and a markedly greater requirement for insulin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A distinguishing feature is concurrent pancreatic exocrine insuf fi ciency (consider screening individuals with acute and chronic pancreatitis for exocrine pancreatic insuf fi ciency by measuring fecal elastase), pathological pancreatic imaging (endoscopic ultrasound, MRI, and computed tomography), and absence of type 1 diabetes -associated autoimmunity (116 -120).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [117]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 1×
“diabetes without preceding pancreatic disease, diabetes after acute pancreatitis, and diabetes after chronic pancreatic disease (27).”
BackgroundRegression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 1×
“We initially created Cox proportional hazards models to assess the hazard of progression to insulin; however, these failed proportional hazards testing (28,29).”
MethodInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · cited 1×
“control as HbA1c $7% (53 mmol/mol), according to the generic target of the American Diabetes Association and the European Association for the Study of Diabetes hyperglycemia guidelines (24).”
MethodThe Regression Analysis of Binary Sequences
Cox, D. R. (1958) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1958.tb00292.x · Cited by 2,813 · cited 1×
“We created logistic regression models for odds of poor glycemic control at 1 year and at 5 years (26).”
MethodType 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
Hart, P. A., Bellin, M. D., Andersen, D. K., Bradley, D., Cruz-Monserrate, Z., Forsmark, C. E., Goodarzi, M. O., Habtezion, A., Korc, M., Kudva, Y. C., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30106-6 · Cited by 551
Natural Course in Chronic Pancreatitis
Lankisch, P. G., Löhr-Happe, A., Otto, J., & Creutzfeldt, W. (1993) · Digestion · doi:10.1159/000201029 · Cited by 452 · cited 1×
“This form of diabetes results when a process, such as inflammation, neoplasia, or surgical resection, disrupts the global architecture or physiology of the pancreas, often resulting in both exocrine and endocrine dysfunction (2,3).”
BackgroundNewly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis
Das, S. L. M., Singh, P. P., Phillips, A. R. J., Murphy, R., Windsor, J. A., & Petrov, M. S. (2014) · Gut · doi:10.1136/gutjnl-2013-305062 · Cited by 401 · cited 1×
“sulin if monitored beyond 5 years (17).”
Cited by
Items 201–284 of 284
A patient with Chronic Calcific Pancreatitis: the Task with Many Unknowns
As, A., Moscow, R. F., Av, S., Pashkova, E. Y., Rumer, V. B., Amikishieva, K. A., & Antsiferova, D. M. (2023) · Doctor Ru · doi:10.31550/1727-2378-2023-22-8-55-60 · Cited by 2
Bogdanski, A. M., Onnekink, A. M., Inderson, A., Boekestijn, B., Bonsing, B. A., Vasen, H. F. A., van Hooft, J. E., Boonstra, J. J., Mieog, J. S. D., Wasser, M. N. J. M., et al. (2024) · Pancreas · doi:10.1097/mpa.0000000000002335 · Cited by 3
“29 The International Cancer of the Pancreas Screening (CAPS) consortium guideline recommends including glucose measurement in routine monitoring; however, its effectiveness has not been proven yet in surveillance of HRIs next to longitudinal imaging, as acknowledged by the guideline.”
Diabetes mellitus in the outcome of acute and chronic pancreatitis. The current state of the problem
As, A., Pashkova, E. Y., Antsiferova, D. M., & Amikishieva, K. A. (2024) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2024-13-1-45-57 · Cited by 2
Identification of key genes and pathways associated with diabetes of the exocrine pancreas
Yang, Z., Li, S., Liu, H., Su, Q., Li, X., Qiu, Y., & Mo, W. (2022) · Medicine · doi:10.1097/md.0000000000029781 · Cited by 2
“[4] Acute and chronic pancreatitis are the most common causes of DEP.”
Serrano, J., Rinaudo, J. A., Srivastava, S., Ghosh, S., Ünalp–Arida, A., & Andersen, D. K. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000758 · Cited by 3
Diabetes, Part 1: Disease State Review
Cornell, S. A. (2022) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2022.139 · Cited by 2
Devouge, A., Foussard, N., Poupon, P., Monlun, M., Blanco, L., Mohammedi, K., & Rigalleau, V. (2019) · Diabetes Care · doi:10.2337/dc19-1504 · Cited by 2
Editorial: Interaction between endocrine and exocrine pancreas
Li, L., & Pandol, S. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.967066 · Cited by 4
Diabetes from Exocrine Pancreatic Disease
Fujimori, N., Ito, T., & Ogawa, Y. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch56 · Cited by 2
Pankreas-Diabetes: Häufig fehldiagnostiziert
Kerner, W. (2018) · Deutsches Ärzteblatt · doi:10.3238/persdia.2018.04.27.02 · Cited by 2
Дудка, І. В., Хухліна, О. С., Дудка, Т. В., Voyevidka, О. S., & Рощук, О. (2023) · Wiadomości Lekarskie · doi:10.36740/wlek202307111 · Cited by 1
Дудка, І. В. (2025) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.25.1.4 · Cited by 1
“Епідеміологічні дані щодо цього типу ЦД при ХП наразі невідомі, однак є окремі повідомлен-ня, які вказують на показник частоти у межах 40– 60% від загальної захворюваності на ХП [8].”
Hariri, H. M., Wahab, S. A., Johnston, M. E., Surapaneni, S., Pratt, C. G., Szu-Aun, L., Hanseman, D. J., Ahmad, S. A., Patel, S. H., & Wilson, G. C. (2025) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2025.116482 · Cited by 1
Diabetes mellitus tipo 3C secundario a pancreatitis crónica: caso clínico
Vargas, J. G. M., Gamboa, K. A., López, D. R. C., Barbosa, L. L. C., & Rodríguez, L. J. V. (2025) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.1223 · Cited by 1
Sun, L., Jiang, M., Wang, X., Sun, Y., Tu, Y., Li, Z., Peng, L., & Huang, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1822750 · Cited by 1
Huang, Y., Zhu, Y., Xia, W., Xie, H., Yu, H., Chen, L., Shi, L., & Yu, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111862 · Cited by 2
Diagnosis and risk factors in pancreatogenic diabetes
Sharma, R. K., Singh, A., & Dawra, S. (2026) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.10.003 · Cited by 1
Hu, R., Chen, Y.-L., Li, G.-J., Luo, Y.-D., Zhou, D., Wang, Z.-G., Zhang, X., Song, Z., Chen, W., & Yang, H. (2026) · BMC Medical Imaging · doi:10.1186/s12880-026-02258-7 · Cited by 1
“Previous research primarily concentrated on identifying risk factors and clinical outcomes associated with PPDM-A, but stable and precise predictive models for PPDM-A complications were lacking [7–15].”
Diabetes und Gastroenterologie – Update 2017
Bojunga, J., & Mondorf, A. W. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0351-x · Cited by 1
“In 316 Der Diabetologe 5 · 2018 Anbetracht einer evtl. begleitenden exokrinen Pankreasinsuffizienz und dem erhöhten Pankreaskarzinomrisiko ist eine Abgrenzung zum T2DM indiziert.”
BackgroundInfluentialDiabetes bei chronischer Pankreatitis
Masseli, J., & Peiffer, K. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00825-w · Cited by 1
de Farias, M. E. B., Queiroz, D., & Victor, F. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_37 · Cited by 1
Pancreatic cancer, pancreatogenic diabetes, type 2 diabetes mellitus
Друк, И. В. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-205-9-171-182 · Cited by 1
P, D. J., N, D. P. K., A, V. M., & A, R. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i3.36672 · Cited by 1
Scherbaum, W. A. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00732-0 · Cited by 1
Clinical characteristics of endocrinopathies in Chinese patients with hereditary haemochromatosis
Wu, H., Yu, M., Xiao, C., Zhang, Q., & Xiao, X. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3448 · Cited by 3
“In these HH patients, blood glucose control is difficult, and the incidence of microvascular complications is higher.(11)”
BackgroundNew-onset diabetes secondary to acute pancreatitis: An update
Yu, X., & Zhu, Q. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i30.10862 · Cited by 1
Gao, L., Ke, L., & Li, W. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.052 · Cited by 1
Diabetes Mellitus Related to Diseases of the Exocrine Pancreas (Pancreatogenic Diabetes)
Bradley, D. A., & Hart, P. A. (2021) · Wiley eBooks · doi:10.1002/9781119570097.ch80 · Cited by 1
Price, C. A., Claridge, H., de Lusignan, S., Khalaf, N. I., Mold, F., Smith, N. A. S., Winn, M., & Lemańska, A. (2024) · medRxiv · doi:10.1101/2024.05.21.24307690 · Cited by 1
More Than Stress Hyperglycemia: Acute Pancreatitis as a Prelude to Diabetes
EGAN, A., & Vella, A. (2026) · Diabetes Care · doi:10.2337/dci26-0048 · Cited by 1
A Neurological Perspective upon Diabetes and Obesity, What They Are, and How They Can Be Measured
Ewing, G. W. (2018) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2018.74025 · Cited by 6
“2 diabetes and complex variants thereof [7] [9] [10] [11] [76].”
BackgroundRare and unexpected cause of diabetes in a teenager
Makaya, T., Ali, A., & Basu, S. (2019) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2018-315857
Pankreopriver Diabetes mellitus: Risikofaktoren und Diagnostik
Siegel, E. G. (2019) · Diabetes aktuell · doi:10.1055/a-0959-5423
“Die Inzidenz für einen pankreopriven Diabetes lag bei 2,59/100 000 Patienten/Jahr und war damit häufiger als ein Typ1Diabetes (1,64/100 000 Patienten/Jahr) [3].”
BackgroundInfluentialLiao, Z., Qian, Y., Zhao, Z., & Li, Z. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.09.010
Diabète de type 2 ? Non, diabète 3c
J.-M., M. (2017) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(17)30388-x
CME: Gibt es schlanke Patientinnen und Patienten mit Typ-2-Diabetes? CME-Fragen
Danioth, S., & Wiesli, P. (2022) · Praxis · doi:10.1024/1661-8157/a003915
82-Year-Old with Weight Loss and New-Onset Diabetes
Nickolis Martin, B. A., Kevin Dileanis, B. S., Lovato, C. M., & Fleg, A. (2022) · Clinical Reviews & Cases · doi:10.33425/2689-1069.1045
Research Progress of Diabetes Mellitus after Acute Pancreatitis
夏, 晶. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1371515
Phillips, M. (2023) · Wiley eBooks · doi:10.1002/9781119809128.ch13
Secondary diabetes mellitus: focusing on type 3c diabetes and post-immunotherapy new onset diabetes
Ragni, A. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.2.8
Pancreatitis and Its Relationship to Diabetes
Almasri, Y., & Hammoud, T. (2023) · International Journal of Clinical Case Reports and Reviews · doi:10.31579/2690-4861/320
Pancreatic and Biliary Tract Cancers
Ney, A., Osei‐Bordom, D., García-Sampedro, A., Acedo, P., Fusai, G., Stott, M. C., Hopley, P. J., Patel, C., Oldfield, L. S., Greenhalf, W., et al. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch17
New-onset Diabetes Mellitus after EUS-guided Drainage with LAMS: A Pilot Study
Man, T., Sfara, A. S., Neamți, L., Istrate, A., Marta, M. M., Pojoga, C., Seicean, R., Rednic, V., & Seicean, A. (2024) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-5142
Wang, Z., Zhang, G., Fu, J., Li, G., Zhao, Z., Choe, H., Ding, K., Ma, J., Wei, J., Shang, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52956-x
“We examined the clinical features of several groups and discovered a significant discrepancy in age and BMI between patients with IGT or DEP and those with ND, in line with previous population-based studies 1,35–37 .”
ResultVirú-Loza, M. A. (2023) · Anales de la Facultad de Medicina · doi:10.15381/anales.v84i4.26187
Tuo, L., & Yiman, W. (2024) · Journal of Nephrology & Endocrinology Research · doi:10.47363/jone/2024(4)130
“Besides, PPDM-A is characterized by poor glycemic control, frequent hypoglycemia attacks and high risk of pancreatic cancer [3,8,9].”
BackgroundComité de Cáncer. Detección de cáncer de páncreas en pacientes con diabetes mellitus
Maraschio, M., Buso, C. J., Croxato, M. E., & Maltagliatti, D. (2024) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v58i1sup.756
Chronic Calcific Pancreatitis, Type IIIc Diabetes Mellitus: A Case Report from Chennai, India
Kirthikaraju Kirthikaraju, K., Saravanakumar, K., & Muppa, L. (2024) · Indian Journal of Pharmacy Practice · doi:10.5530/ijopp.17.3.45
Introduction to the issue: acute pancreatitis and related metabolic complications
Yadav, D. K., Hart, P. A., & Bellin, M. D. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001044
Hart, P. A., & Andersen, D. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00056-x
Advances in research of metabolic bone disease secondary to chronic pancreatitis
Yang, F., Xu, J.-J., & Hu, L. (2025) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v33.i2.89
“与 2 型糖尿病相比 , 胰源性糖尿病患 者对胰岛素的需求更高、血糖控制更差 , 且与不良结局 相关 [24,25] .”
Xu, J., Deng, N., Zhang, Z., Deng, M., & Luo, G. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.arteri.2025.500800
Pankreatojenik (Tip3c) Diyabet ve Hemşirelik Bakımı
Kasalar, I. (2025) · Turkish Journal of Diabetes Nursing · doi:10.29228/tjdn.79370
Research Status and Advancements in Post-Acute Pancreatitis Diabetes Mellitus
Zeng, Y., & Li, H. (2025) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2025.07(07).01
Ye, J., Xie, J., Wang, Y., Ru, N., Mao, X., Li, T., Qian, Y., Zou, W., Cao, Y. Q., & Liao, Z. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-092777
Lugovaya, L. A., Занозина, О. В., Анатольевна, Н. Т., Bolshova, U. R., & Alekseev, E. A. (2025) · FOCUS Endocrinology · doi:10.62751/2713-0177-2025-6-3-13
Maruyama, T., Aono, T., Suzuki, S., Kajiyama, Y., Aizawa, K., Nakajima, K., Miura, Y., Kaneko, K., Sato, T., & Okada, T. (2025) · 日本消化器外科学会雑誌 · doi:10.5833/jjgs.2024.0113
Tu, X., Liu, Q., Chen, L., Li, J., Yu, X., Jiao, X., Wang, N., Hu, L., Yuan, Y., Gong, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23606959
Tu, X., Liu, Q., Chen, L., Li, J., Yu, X., Jiao, X., Wang, N., Hu, L., Yuan, Y., Gong, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23606962
Tu, X., Liu, Q., Chen, L., Li, J., Yu, X., Jiao, X., Wang, N., Hu, L., Yuan, Y., Gong, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23606956
Additional file 1 of Galantamine ameliorates experimental pancreatitis
Thompson, D., Tsaava, T., Rishi, A., George, S. J., Hepler, T. D., Hyde, D., Pavlov, V. A., Brines, M. L., Chavan, S. S., & Tracey, K. J. (2023) · Figshare · doi:10.6084/m9.figshare.24472494
Tu, X., Liu, Q., Chen, L., Li, J., Yu, X., Jiao, X., Wang, N., Hu, L., Yuan, Y., Gong, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23606953
Spontaneous diabetic remission after acute pancreatitis in a dog
Claude, R. J., Mott, J., & Gilor, C. (2026) · Journal of Veterinary Internal Medicine · doi:10.1093/jvimsj/aalaf035
Евгеньевич, Е. А., Minushkin, O. N., Владимирович, З. И., & Maslovskii, L. V. (2026) · Medical alphabet · doi:10.33667/2078-5631-2025-34-21-27
Jia, X., Li, X., Lian, R., Ma, B., & Ma, X. (2026) · European journal of medical research · doi:10.1186/s40001-026-04007-6
“International studies indicate that up to 87.8% of T3cDM patients are initially misclassified as having type 2 diabetes (T2DM), with only 2.7% receiving a correct diagnosis [8].”
InfluentialTorres-Cuevas, I., Sánchez‐López, C. M., Marcilla, A., & Garrido, S. P. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.145 · Cited by 1
Demir, B. F., Comoglu, E., Şahiner, E. S., Kilic, Z. M. Y., & Ateş, İ. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103943
“Previous studies and meta-analyses have reported that approximately 15% of patients develop diabetes within the first year after acute pancreatitis, with the cumulative incidence reaching 20–40% over longer follow-up periods [5–8].”
Genetic predisposition to diabetes mellitus causally increases acute pancreatitis risk
Wang, Y.-M., Wei-yi, Z., Lu, Y.-X., Li, B.-J., Shi, Y.-Q., & Li, T. (2026) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.221
Quantifying Weight Loss Prior to Pancreatic Cancer Diagnosis: A Systematic Review and Meta‐Analysis
Price, C. A., Cooke, D. D., Mold, F., Smith, N. A. S., Winn, M., & Lemańska, A. (2026) · Cancer Medicine · doi:10.1002/cam4.71997
Balamir, M., Avci, B., Coşan, E., Tanyolaç, S., Çavuş, B., Örmeci, A. Ç., Akyüz, F., Besisik, S. F., Kaymakoğlu, S., Hacışahinoğulları, H., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15114319
“[22].”
Cheng-cheng, T., Hu, C., Liu, X.-Y., Shen, Y.-Y., Wu, Y., Zhang, L.-X., & Mei, Q. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.124070
Type 5 diabetes mellitus: revisiting malnutrition-related diabetes
Hryncewicz, M., Kostrzewska, P., Kuca, P., Łaz, R., Migda, A. M., & Witek, P. (2026) · Endokrynologia Polska · doi:10.5603/ep.111734
Shah, R., & Vora, T. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101786
Bruggeman, B. S., Jacobsen, L. M., Foster, T. P., & Winter, W. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21725-8.00013-5
Research Progress and Clinical Management Strategies of Post-Acute Pancreatitis Diabetes Mellitus
关, 敏. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1683003
As, A., Shabunin, A. V., Pashkova, E. Y., & Amikishieva, K. A. (2026) · Doctor Ru · doi:10.31550/1727-2378-2026-25-3-7-14
Ba, D. M., Sadr, A. V., Zhang, Y., Hart, P. A., Raja-Khan, N. T., Zhou, R., Siddiqui, A., Qiu, T., Maranki, J. L., Chinchilli, V. M., et al. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-004661
Ciccarelli, G., Giorgi, N. D., Iacomini, C., Masciocchi, C., Patarnello, S., Giuseppe, G. D., Lucia, S. S. D., Nista, E. C., Gasbarrini, A., Pontecorvi, A., et al. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261419207
Meden, A., & Tramšek, N. A. K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1963887
“Misclassi fi cation as type 1 or type 2 diabetes makes both epidemiology and patient-experienced burden dif fi cult to de fi ne (2, 3).”
Pancreatogenic Diabetes Mellitus – Type 3c (T3cDM)
Solil, D., Dítě, P., Bojková, M., Kojecký, V., Dolina, J., & Kianička, B. (2026) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-7071
Diagnosis and management of type 3c diabetes– a consensus statement by Endocrine Society of Bengal
Agrawal, N., Baidya, A., Banerjee, M., Basu, A. K., Bhattacharjee, R., Biswas, S. N., Chakraborty, P. P., Chakraborty, S., Chatterjee, C., Chatterjee, S., et al. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.09.020
Diabetes Mellitus: Review of the Common, Rare, and Uncommon (Conceptual and Metaphorical) Types
Pliszka, M., & Szablewski, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219611
Metadata
- Authors
- Woodmansey, C., McGovern, A. P., McCullough, K. A., Whyte, M. B., Munro, N. M., Correa, A. C., Gatenby, P. A. C., Jones, S. A., & de Lusignan, S.
- Affiliations
- University of Surrey (GB)
- Royal Surrey County Hospital (GB)
- Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-31
- Volume
- 40
- Issue
- 11
- Pages
- 1486-1493
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2752023293
- Cited by
- 280
- References
- 36
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 36 · 2023: 33 · 2022: 38 · 2021: 34 · 2020: 29 · 2019: 28 · 2018: 25 · 2017: 3
- FWCI
- 23.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Funders
- National Institute for Health and Care Research (ACF-2017-23-003)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 3c diabetes, type 2 diabetes, incidence, acute pancreatitis, chronic pancreatitis, glycemic control, insulin requirement, HbA1c, primary care records
- MeSH terms
- Acute Disease, Adult, Aged, Aged, 80 and over, Blood Glucose, Chronic Disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, England, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hyperglycemia, Insulin, Male, Middle Aged, Pancreatitis, Primary Health Care, Retrospective Studies, Risk Factors, Body Mass Index, Incidence, Pancreas, Exocrine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.